Cargando…

The LDL-C/Apo B predicts coronary atherosclerotic heart disease in non-diabetic patients without high LDL-C

The apolipoprotein B (Apo B), Apo B/A1 ratio, lipoprotein (a), and low-density lipoprotein cholesterol (LDL-C)/Apo B ratio are associated with coronary artery disease (CAD). However, the association between these parameters and CAD in non-diabetic patients without high LDL-C levels is unclear. Our g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Hae Won, Ra, Moni, Bae, Han Joon, Hong, Seung-Pyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829249/ https://www.ncbi.nlm.nih.gov/pubmed/36607865 http://dx.doi.org/10.1097/MD.0000000000032596

Ejemplares similares

Comparison of Framingham risk score and pooled cohort equations for the prediction of coronary atherosclerosis in patients who meet the target LDL-C level of Korean dyslipidemia guideline
por: Kim, Su Bin, et al.
Publicado: (2022)

Association of rs2000999 in the haptoglobin gene with total cholesterol, HDL-C, and LDL-C levels in Mexican type 2 diabetes patients
por: Suarez-Sanchez, Fernando, et al.
Publicado: (2019)

Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention
por: Zhang, Wenduo, et al.
Publicado: (2017)

The Comparison of the Associations of Lipoprotein(a) and the Atherogenic Index of Plasma With Coronary Artery Calcification in Patients Without High LDL-C: A Comparative Analysis
por: Hong, Seung-Pyo, et al.
Publicado: (2023)

Effects of Serum LDL-C, CysC, and D-D in Patients with Coronary Atherosclerotic Heart Disease
por: Shen, Chaofeng, et al.
Publicado: (2022)

Predictive value of LDL/HDL ratio in coronary atherosclerotic heart disease
por: Sun, Ting, et al.
Publicado: (2022)

Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study
por: Yao, Tianci, et al.
Publicado: (2022)

The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL
por: Li, Chuang, et al.
Publicado: (2021)

Altered Expression of TXNIP in the peripheral leukocytes of patients with coronary atherosclerotic heart disease
por: Zhang, Yujing, et al.
Publicado: (2017)

Association of decreased serum sTREM-1 level with the severity of coronary artery disease: Inhibitory effect of sTREM-1 on TNF-α- and oxLDL-induced inflammatory reactions in endothelial cells
por: Dai, Daopeng, et al.
Publicado: (2016)

Regulation of plasma LDL: the apoB paradigm
por: Sniderman, Allan D., et al.
Publicado: (2009)

Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure
por: Zhao, Qin, et al.
Publicado: (2017)

Impact of diabetes duration on heart failure in Korean patients without clinical cardiovascular disease
por: Noh, Minsu, et al.
Publicado: (2019)

The relationship between fetuin-A and coronary atherosclerotic heart disease (CHD) and CHD-related risk factors: A retrospective study
por: Zheng, Jianping, et al.
Publicado: (2021)

Coronary heart disease is associated with nonalcoholic fatty liver disease in patients without hypertension and diabetes
por: Liu, Zipeng, et al.
Publicado: (2020)

Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II
por: Shahid, Saleem Ullah, et al.
Publicado: (2016)

Objectifying the level of incomplete revascularization by residual SYNTAX score and evaluating the impact of incomplete revascularization on exercise tolerance in patients with coronary atherosclerotic heart disease treated by percutaneous coronary intervention
por: Xue, Lin, et al.
Publicado: (2020)

Associations between Oxidized LDL to LDL Ratio, HDL and Vascular Calcification in the Feet of Hemodialysis Patients
por: An, Won Suk, et al.
Publicado: (2009)

Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
por: Albosta, Michael S, et al.
Publicado: (2023)

LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker
por: Aggarwal, Dr Jyoti, et al.
Publicado: (2021)

Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study
por: Komiya, Ichiro, et al.
Publicado: (2021)

The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population
por: Xiao, Li, et al.
Publicado: (2023)

Mechanism of Yiqi Huoxue Huatan recipe in the treatment of coronary atherosclerotic disease through network pharmacology and experiments
por: Huang, Hong-Tao, et al.
Publicado: (2023)

The lack of association between different LDL‐C levels and oxidized LDL in patients with type 2 diabetes
por: Rabizadeh, Soghra, et al.
Publicado: (2023)

The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report
por: Li, Yu-Feng, et al.
Publicado: (2015)

The Role of Fasting LDL-C Levels in Their Non-fasting Reduction in Patients With Coronary Heart Disease
por: Lin, Qiuzhen, et al.
Publicado: (2021)

Evaluating LDL-C control in Indian acute coronary syndrome (ACS) patients- A retrospective real-world study LDL-C control in ACS
por: Jain, Madhur, et al.
Publicado: (2023)

Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction
por: Bin Waleed, Khalid, et al.
Publicado: (2020)

MTHFR C677T gene polymorphism and the severity of coronary lesions in acute coronary syndrome
por: Li, Miao-Nan, et al.
Publicado: (2017)

Clinical Impact and Cost-Effectiveness of Coronary Computed Tomography Angiography or Exercise Electrocardiogram in Individuals Without Known Cardiovascular Disease
por: Park, Gyung-Min, et al.
Publicado: (2015)

Association of cytochrome P450 2C19 polymorphisms with coronary heart disease risk: A protocol for systematic review and meta analysis
por: Yang, Yongxin, et al.
Publicado: (2020)

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
por: Clem, James R, et al.
Publicado: (2009)

Transiently Elevated TC and sdLDL-C Levels and Falsely Low LDL-C Levels in Patients with Extrahepatic Cholangiocarcinoma
por: Guo, Yi, et al.
Publicado: (2021)

LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone
por: Enomoto, Mika, et al.
Publicado: (2011)

Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients
por: Otrante, Alyann, et al.
Publicado: (2023)

Risk Score Model for the Assessment of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes
por: Park, Gyung-Min, et al.
Publicado: (2015)

Novel circulating lipid measurements for current dyslipidemias in non-treated patients undergoing coronary angiography: PCSK9, apoC3 and sdLDL-C
por: Li, Sha, et al.
Publicado: (2016)

Evaluation of different formulas for LDL-C calculation
por: Vujovic, Ana, et al.
Publicado: (2010)

Evidence-based goals in LDL-C reduction
por: Soran, Handrean, et al.
Publicado: (2017)

Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents
por: Konrad, Robert J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b190t79lsc6ft34f5dhlsm8cbg